Alzheimer's Association Research Grant For All (AARGA) 2026: Up to $200,000 for Early-Career Dementia Researchers
The Alzheimer’s Association’s 2026 AARGA cycle is open only to investigators invited after an approved letter of intent. The LOI deadline has passed; invited applicants may submit full applications by October 20 (October 22 for ISTAART attendees). No later cycle is announced on the official page.
This captured cycle appears closed. Use this page for historical guidance unless the official source has reopened the program.
Captured cycle: This page is retained for historical guidance. Confirm whether the program has reopened before planning an application.
Alzheimer’s Association Research Grant For All (AARGA) 2026: Up to $200,000 for Early-Career Dementia Researchers
The Alzheimer’s Association Research Grant For All (AARGA) is an individual research grant for early-career investigators who have recently become independent. The Association designed it to help a new assistant professor generate preliminary or pilot data, test procedures, and develop hypotheses that can support a future application to a federal or other research funder. It covers Alzheimer’s disease and related dementias across basic, translational, clinical, and psychosocial research.
The 2026 cycle is still accepting full applications from investigators whose letter of intent (LOI) was approved and who were invited by Association staff. The LOI deadline was August 14, 2026, at 5 p.m. Eastern Time, so no new applicant can enter this round. Invited applicants must submit a full application by October 20, 2026, at 5 p.m. Eastern Time, or October 22, 2026, at 5 p.m. Eastern Time, for ISTAART attendees. A ProposalCentral account or visible application form does not replace the Association’s invitation. The official AARGA page and its 2026 request for applications do not announce a later cycle; applicants who missed the LOI should wait for a new official call.
2026 cycle at a glance
| Item | 2026 cycle information |
|---|---|
| Programme | Alzheimer’s Association Research Grant For All (AARGA) |
| Running organisation | Alzheimer’s Association |
| Award ceiling | $200,000 total for a three-year award |
| Annual limit | $70,000 per year, including direct and indirect costs |
| Minimum and maximum duration | Two years minimum; three years maximum |
| Indirect costs | Up to 10% of total direct costs, including subcontract indirect costs |
| LOI deadline | August 14, 2026, 5 p.m. ET; passed, and new applicants cannot enter this cycle |
| Full application deadline | October 20, 2026, 5 p.m. ET; October 22 for ISTAART attendees with approved LOIs |
| Award notice | By January 31, 2027 in the RFA; the overview page lists January 30, 2027 |
| Submission platform | ProposalCentral |
| Contact | [email protected] |
The award ceiling and annual cap must be read together. A two-year proposal cannot request the full $200,000 because no year may exceed $70,000 in combined direct and indirect costs; three years is the maximum project duration. The budget should therefore reflect the specific pilot work and the institution’s actual costs. The Association says most of the award should support direct research, and indirect costs are limited to 10% of total direct costs. That limit includes indirect costs for the applicant institution and for subcontracts.
The RFA also describes the Debbie & Clay Jones Alzheimer’s Research Leadership Awards. Based on review, the two top-ranked AARGA awardees in the cycle may each be named Jones Awards Scholars and receive an additional $50,000 over the grant period for professional development and research needs. This is conditional recognition, not part of every AARGA award or a guaranteed amount to include in a standard AARGA budget. Canadian-led applications may also be considered for a partnership with Brain Canada Foundation, as described in the RFA.
Purpose and suitable projects
AARGA is intended to help a newly independent researcher build evidence for the next stage of a research programme. The RFA describes projects across the full spectrum of Alzheimer’s disease and related dementias, provided the proposal has a strong scientific rationale. Example areas include disease mechanisms, biomarkers, therapeutic targets, epidemiology, neuroimaging, care interventions, and health equity. Basic laboratory work, translational projects, clinical research, and psychosocial investigations can all fit.
The central planning question is what decision or next study the award will make possible. A pilot might establish that a recruitment pathway can reach a group missing from existing cohorts, that a measure performs adequately in a new setting, or that a mechanistic signal merits a larger experiment. A useful proposal links its workplan to a plausible follow-on grant or other research application. The programme is meant to lay that groundwork; applicants should make the relationship explicit instead of presenting a small project as if it could settle a broad clinical or biological question on its own.
The application is an individual research grant administered through the recipient’s institution. Teams can contribute, but each proposal has one primary principal investigator. Collaborators and key personnel are allowed and should have clear roles. The Association encourages applicants from underrepresented groups and values broad representation in dementia research. The project still needs a clear connection to Alzheimer’s disease or a related dementia, a well-supported question, and methods suited to answering it.
Who was eligible
The applicant needed a doctoral degree, such as a Ph.D. or equivalent, and a full-time Assistant Professor position or equivalent at a not-for-profit academic, medical, or research institution. Research Assistant Professor roles count. The applicant could be based in the United States or internationally. A part-time, temporary, or acting faculty position did not meet the RFA’s requirements, and someone already above Assistant Professor rank or in an equivalent senior leadership position was ineligible.
The career-stage rule was no more than seven years in Assistant Professor-equivalent titles at the time of LOI submission. Time in a Research Assistant Professor appointment counts toward that limit. The RFA allows the Association to consider adjustments for documented career interruptions, including family leave, military service, or major illness or injury. Any exemption had to be requested and approved before the LOI deadline; it was not an automatic extension. Because the LOI date has passed, the eligibility calculation for this round is anchored to August 14, 2026, rather than to the date someone reads this page.
Eligible applicant institutions generally include nonprofit public or private research laboratories, medical centers, hospitals, and universities. For-profit entities cannot serve as the applicant institution. State and federal government-appropriated laboratories in the United States and abroad are also prohibited from applying as the institution, with an exception for Veterans Administration hospitals; government scientists can participate as collaborators with an eligible applicant institution. Institutions must provide current nonprofit verification: the RFA specifies a W-9 for U.S. entities or a W-8/W-8-BEN for international entities, signed within the required five-year period and carrying the relevant tax or VAT identifier. The RFA gives additional documentation rules for some non-academic nonprofits.
Only one primary PI is permitted. Applicants also could submit only one application in the cycle across AARGA and the Alzheimer’s Association Clinical Scientist Fellowship For All (AACSFA). The official page’s wording repeats AARGA in its description of that one-application rule, while the RFA states the two programmes directly. Researchers considering overlapping Association funding or a related fellowship should consult the RFA and [email protected] about project overlap before making assumptions.
How the 2026 application was structured
The first required submission was a letter of intent through ProposalCentral. The LOI was a screening stage, not an optional notice of interest: only a fraction of LOIs were invited to submit full applications. The full application PI had to be the same person who submitted the approved LOI. The 2026 LOI window ended on August 14, so a new applicant cannot enter this cycle now. Investigators who received an approval email may still submit a full application by October 20 (October 22 for ISTAART attendees). The Association says not to submit without its approval email, even if ProposalCentral makes an application visible.
The LOI had to be blinded. Its body could not contain personally identifying information such as the applicant’s name, institution, location, or other identifiers; the RFA warns that a submission containing identifying details could be disqualified or returned. Applicants completed the required ProposalCentral sections and supplied applicant and institution information, the PI’s current academic position and ORCID, lead institution details, and nonprofit verification. Scientific information included the proposal title, research area, a short project description, aims, novelty, and expected impact on Alzheimer’s and related dementia research. The RFA limits each short project-description field to 1,000 characters including spaces. The PI’s biosketch was part of the LOI; biosketches for other team members could be provided at the full application stage.
LOIs were assessed in blinded review by two or three reviewers with relevant expertise. They considered innovation or novelty, the project’s impact on Alzheimer’s and dementia research, and methodological rigor. Individual feedback was not promised at the LOI stage. Approved applicants received communication from Association staff inviting them to proceed. If that invitation was absent, the RFA says not to submit a full application even if ProposalCentral displayed an application.
An invited full application was also submitted through ProposalCentral. Its listed components included a one-page problem statement; a five-page workplan covering rationale, strategy, alternatives, and expected outcomes; a recruitment plan for studies involving human volunteers; a data analysis plan with statistical and power considerations; references; a data management and sharing plan; PI and applicable key-personnel biosketches; nonprofit documentation; an environmental context; an available-resources statement; and a budget justification within its two-page limit. A resubmission statement of up to one page was optional for a revised proposal. Applicants should follow the RFA and the application instructions in ProposalCentral for exact formatting and upload requirements.
The environmental context gives the panel information about where the work will happen: available facilities, community relationships, partnerships, geographic setting, infrastructure, and other aspects that affect feasibility. The budget justification should show how requested costs support the workplan. The RFA permits salary for the PI and research staff, laboratory supplies and animal care, core services, publication costs, scientific meeting travel within stated limits, professional development, and some other research expenses. It prohibits categories such as tuition, office or lab rent, visa costs, general institutional overhead on staff time, standard computer hardware, and major equipment. Some purchases require prior approval. Applicants must check the RFA’s specific cost rules instead of assuming that an expense is allowed because it appears in another grant budget.
By submitting an LOI or application, the organization confirmed that it had reviewed the Association’s terms and conditions and would accept them as written. The RFA says those conditions are non-negotiable. Institutional grants staff therefore needed to review them before the application was submitted. Late submissions were not accepted, and ProposalCentral confirmation mattered: after submission, applicants were directed to make sure the proposal status showed “Submitted,” not “In Progress.”
Review, award, and status
Full applications go through a multi-stage peer-review process. Peer scientists with expertise in the proposed area rate applications against the scientific question, the PI and collaborators’ qualifications, the environmental context, workplan quality, recruitment where human volunteers are involved, resources and budget, and the proposal’s potential contribution to the field. The RFA allows applicants to recommend reviewers and to identify specific reviewers to exclude when there is a conflict of interest. Examples include recent co-publication or co-investigator relationships, prior training relationships, financial benefit, or a conceptual conflict that could prevent fair review.
The International Research Grant Program Council and invited reviewers then discuss initial scores and comments, with the aim of calibrating recommendations across reviews and programmes. The Medical and Scientific Advisory Group and the Council consider final recommendations before they are shared with the Association for funding decisions. The RFA schedules award notices by January 31, 2027, while the overview page currently says by January 30, 2027; both official materials place notification at the end of January. Awards are expected to begin within three months after notification.
At the time checked for this update, the official AARGA page still provides the 2026 RFA and application links. It does not announce a subsequent LOI window or next cycle. Full applications for the current round remain open only to people whose LOIs were approved and who were invited; the October 20 deadline (October 22 for ISTAART attendees) is therefore the live deadline for that limited group. Applicants who did not submit an LOI by August 14 cannot join this round and should wait for a new official announcement before relying on these requirements for a later year.
Official links and contact
- Alzheimer’s Association AARGA programme page
- 2026 AARGA request for applications
- ProposalCentral application portal
- Questions: [email protected]
Applicants invited to finish the 2026 round should use the Association’s RFA and ProposalCentral instructions for their submission. Everyone else should wait for the Association to announce a new LOI window, then verify its deadline and eligibility terms; the 2026 requirements here should not be used as a substitute for documents issued for a later cycle.